Generic Name and Formulations:
Fluocinolone acetonide 0.19mg; implant for intravitreal inj.
Indications for ILUVIEN:
Diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids without a significant rise in intraocular pressure.
Give by intravitreal inj. See full labeling for administration.
Ocular or periocular infections. Glaucoma.
Monitor for increased intraocular pressure and endophthalmitis; may include check for perfusion of the optic nerve head immediately, tonometry within 30 mins, and biomicroscopy between 2–7 days post inj. Risk of secondary ocular infections (eg, bacterial, fungal, viral). History of ocular herpes simplex: not recommended. Risk of implant migration if absent or torn posterior capsule of the lens. Pregnancy (Cat.C). Nursing mothers.
Cataract development, increased intraocular pressure; injection-related effects (eg, endophthalmitis, eye inflammation, retinal detachments), others.
Single-use applicator—1 (w. needle)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- Coping Strategies for Amplified Emotionality May Improve Bipolar Disorder Symptoms
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Digital Media Engagement Associated With ADHD Symptoms in Adolescents